Stephen J. Thomas

28.6k total citations · 2 hit papers
173 papers, 5.8k citations indexed

About

Stephen J. Thomas is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Stephen J. Thomas has authored 173 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Public Health, Environmental and Occupational Health, 113 papers in Infectious Diseases and 21 papers in Epidemiology. Recurrent topics in Stephen J. Thomas's work include Mosquito-borne diseases and control (115 papers), Viral Infections and Vectors (92 papers) and Malaria Research and Control (56 papers). Stephen J. Thomas is often cited by papers focused on Mosquito-borne diseases and control (115 papers), Viral Infections and Vectors (92 papers) and Malaria Research and Control (56 papers). Stephen J. Thomas collaborates with scholars based in United States, Thailand and United Kingdom. Stephen J. Thomas's co-authors include Timothy P. Endy, Alan L. Rothman, Robert V. Gibbons, Richard G. Jarman, In‐Kyu Yoon, Ananda Nisalak, Kathryn B. Anderson, Scott B. Halstead, Siripen Kalayanarooj and Daniel H. Libraty and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Stephen J. Thomas

164 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of Dengvaxia®: development to deployment

2019 208 citations Stephen J. Thomas et al. profile →
Is new dengue vaccine efficacy data a relief or cause for concern?

2023 84 citations Stephen J. Thomas profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen J. Thomas United States	44	4.1k	3.7k	718	379	368	173	5.8k
Chwan‐Chuen King Taiwan	42	2.9k 0.7×	3.0k 0.8×	1.1k 1.5×	442 1.2×	415 1.1×	120	5.2k
Marc Fischer United States	39	3.2k 0.8×	3.1k 0.8×	1.1k 1.5×	286 0.8×	188 0.5×	122	4.9k
Tadeusz J. Kochel United States	42	3.4k 0.8×	3.0k 0.8×	980 1.4×	791 2.1×	374 1.0×	121	5.2k
Isabel Rodríguez-Barraquer United States	33	2.1k 0.5×	2.4k 0.6×	412 0.6×	744 2.0×	223 0.6×	88	3.9k
Aubree Gordon United States	37	2.2k 0.5×	3.2k 0.9×	1.3k 1.8×	460 1.2×	502 1.4×	110	4.8k
Timothy P. Endy United States	40	4.6k 1.1×	4.0k 1.1×	476 0.7×	410 1.1×	214 0.6×	112	5.6k
Philippe Buchy Cambodia	47	4.7k 1.1×	4.7k 1.3×	2.5k 3.5×	513 1.4×	690 1.9×	185	8.5k
Henrik Salje United States	36	2.6k 0.6×	3.7k 1.0×	1.2k 1.6×	1.7k 4.4×	273 0.7×	125	6.2k
David Baud Switzerland	40	2.3k 0.6×	1.8k 0.5×	1.3k 1.9×	411 1.1×	664 1.8×	206	6.6k
Antoine Nougaırède France	30	1.8k 0.4×	2.2k 0.6×	806 1.1×	178 0.5×	420 1.1×	99	3.4k

Countries citing papers authored by Stephen J. Thomas

Since Specialization

Citations

This map shows the geographic impact of Stephen J. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Thomas more than expected).

Fields of papers citing papers by Stephen J. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Thomas. The network helps show where Stephen J. Thomas may publish in the future.

Co-authorship network of co-authors of Stephen J. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Thomas. A scholar is included among the top collaborators of Stephen J. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Thomas. Stephen J. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nguyen, Thanh, et al.. (2025). Development and optimization of an mRNA-vectored single-chain IgA1 isotype monoclonal antibody with potential to treat or prevent dengue virus infection. Antiviral Research. 234. 106078–106078. 1 indexed citations

Kufel, Wesley D., et al.. (2025). Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19. Annals of Pharmacotherapy. 59(12). 1086–1093. 2 indexed citations

Kufel, Wesley D., et al.. (2024). A five-year quasi-experimental study to evaluate the impact of empiric antibiotic order sets on antibiotic use metrics among hospitalized adult patients. Infection Control and Hospital Epidemiology. 45(5). 609–617.

Waickman, Adam T., Hengsheng Fang, Jeffrey R. Currier, et al.. (2024). Low-dose dengue virus 3 human challenge model: a phase 1 open-label study. Nature Microbiology. 9(5). 1356–1367. 9 indexed citations

Kufel, Wesley D., et al.. (2023). Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia. Annals of Pharmacotherapy. 58(4). 360–365. 3 indexed citations

Panter, Charlotte, Kevin L. Russell, Madelyn Ruggieri, et al.. (2023). Measuring dengue illness intensity: Development and content validity of the dengue virus daily diary (DENV-DD). Journal of Patient-Reported Outcomes. 7(1). 84–84.

O’Driscoll, Megan, Darunee Buddhari, Angkana T. Huang, et al.. (2023). Maternally derived antibody titer dynamics and risk of hospitalized infant dengue disease. Proceedings of the National Academy of Sciences. 120(41). e2308221120–e2308221120. 15 indexed citations

Kufel, Wesley D., et al.. (2022). Vancomycin plus ceftaroline for persistent methicillin‐resistant Staphylococcus aureus bacteremia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(1). 15–23. 7 indexed citations

Waickman, Adam T., Hengsheng Fang, Jeffrey R. Currier, et al.. (2022). Evolution of inflammation and immunity in a dengue virus 1 human infection model. Science Translational Medicine. 14(668). eabo5019–eabo5019. 23 indexed citations

10.

Steele, Jeffrey M., et al.. (2021). Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections. Journal of Antimicrobial Chemotherapy. 76(6). 1379–1391. 47 indexed citations

11.

Kufel, Wesley D., Jeffrey M. Steele, Dongliang Wang, et al.. (2021). Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management. Diagnostic Microbiology and Infectious Disease. 101(4). 115535–115535. 5 indexed citations

12.

Thomas, Stephen J., John L. Perez, Stephen Lockhart, et al.. (2021). 1558O COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine. Annals of Oncology. 32. S1129–S1129. 9 indexed citations

13.

McCracken, Michael K., Gregory D. Gromowski, Lindsey S. Garver, et al.. (2020). Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques. PLoS neglected tropical diseases. 14(4). e0008191–e0008191. 19 indexed citations

14.

Guy, Bruno, Eng Eong Ooi, José Ramos‐Castañeda, & Stephen J. Thomas. (2020). When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?. Vaccines. 8(2). 174–174. 3 indexed citations

15.

Prompetchara, Eakachai, Chutitorn Ketloy, Stephen J. Thomas, & Kiat Ruxrungtham. (2019). Dengue vaccine: Global development update. Asian Pacific Journal of Allergy and Immunology. 38(3). 178–185. 64 indexed citations

16.

Szaba, Frank M., Michael Tighe, Lawrence W. Kummer, et al.. (2018). Zika virus infection in immunocompetent pregnant mice causes fetal damage and placental pathology in the absence of fetal infection. PLoS Pathogens. 14(4). e1006994–e1006994. 69 indexed citations

17.

Thomas, Stephen J., Liane Agulto, Kay M. Tomashek, et al.. (2018). Dengue illness index—A tool to characterize the subjective dengue illness experience. PLoS neglected tropical diseases. 12(10). e0006593–e0006593. 5 indexed citations

18.

Mogle, Bryan T., et al.. (2017). Clinical review of delafloxacin: a novel anionic fluoroquinolone. Journal of Antimicrobial Chemotherapy. 73(6). 1439–1451. 58 indexed citations

19.

Blackman, Marcia A., In-Jeong Kim, Jr‐Shiuan Lin, & Stephen J. Thomas. (2017). Challenges of Vaccine Development for Zika Virus. Viral Immunology. 31(2). 117–123. 6 indexed citations

20.

Moulton, Steven L., Jane Mulligan, Anon Srikiatkhachorn, et al.. (2016). State-of-the-art monitoring in treatment of dengue shock syndrome: a case series. Journal of Medical Case Reports. 10(1). 233–233. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact